We observed a 14.5-fold increase of RGS2 mRNA expression in nasopharyngeal swabs of COVID-19 patients, compared with controls in both datasets (Padj = 1.7 × 10−5; Figure 1A and FC = 2.4; Padj = 0.001693; Figure 1B). Here, RGS2 is linked to COVID-19.